5055 High efficacy of the combination of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated results of an international phase II trial with a median follow-up of 39 months.

Details

Language :

English

ISSN :

13596349

Volume :

7

Issue :

2

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

44463043

Full Text :

https://doi.org/10.1016/S1359-6349(09)70947-4